Polymorphonuclear leukocytes (PMN) and LPS-binding protein (LBP) are both components of the innate immune system. LBP is a plasma protein that binds to lipid A and enhances the biological activity of LPS 100-to 1000-fold. Recently it was reported that LBP-deficient mice are more susceptible to Salmonella typhimurium infection. Here we report that LBP KO mice are more susceptible to Salmonella peritonitis, but not to oral or i.v. infection. LBP knockout (KO) mice responded normally to i.p. injections of Staphylococcus aureus and casein, but not to i.p. injection of S. typhimurium or Salmonella LPS. Mice with a mutation in Toll-like receptor 4 (C3H/HeJ) have a similar defect in PMN chemotaxis. In normal mice S. typhimurium stimulated production of the CXC chemokines macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant, but levels of cytokine-induced neutrophil chemoattractant and macrophage inflammatory protein-2 were greatly reduced in the LBP KO mice. LBP KO mice pretreated with casein to attract PMN in an LBP-independent manner were more resistant to Salmonella infection, but neutropenic mice were not protected by casein. Splenic TNF-␣ mRNA levels were also lower in LBP KO than in control mice infected with Salmonella. Since TNF-␣ can activate PMN, LBP KO mice may have both fewer and less active PMN in the first few hours after Salmonella are injected, making LBP KO mice more susceptible. This work confirms the importance of PMN in resistance to Salmonella infections and shows that this is facilitated by LBP.
T he innate immune system evolved to enable a host to slow down the net replication of pathogenic microbes that have the capacity to multiply so rapidly that they can overwhelm the host before it can make an adaptive immune response (1) . The innate immune system includes cell surface receptors and circulating proteins that recognize unique, conserved constituents of the microbes, which facilitates recognition of many different potential pathogens, even though the pathogens may have few, if any, Ags in common (2) . One of the signature molecules that activate innate immune responses is the lipid A portion of LPS, the principal constituent of the outer membrane of Gram-negative bacteria. The fatty acid-substituted disaccharide structure of the lipid A is largely conserved (3) , and lipid A is a potent stimulus for many mammalian cells. The binding of LPS to cell surfaces is complex and has not been completely determined, but it involves mCD14 (a glycerophosphoinositol-linked membrane protein) (4), a transmembrane protein (Toll-like receptor 4 (TLR4)
3 ) (5), and MD-2, a secreted cell-bound protein that binds LPS (6, 7) . The initial binding of LPS to CD14 is greatly enhanced by a serum protein, LPS-binding protein (LBP) (8) , which has the ability to catalytically transfer LPS from the outer membrane of Gram-negative bacilli to CD14 at substoichiometric concentrations (in comparison with either LPS or CD14).
LBP is an acute phase reactant that is made by the liver in response to IL-1␤ and IL-6 (9) . LBP binds to the lipid A portion of LPS (10) . LPS bound to LBP is 100-to 1000-fold more potent, as measured by the response of CD14 ϩ cells (11) . Thus, LBP can greatly amplify the toxic potential of LPS. This function for LBP would appear to be paradoxical, since the acute phase response is generally protective, not harmful, to the host. Therefore, it is likely that LBP is also of some benefit during the acute phase of Gramnegative bacterial infections. A number of protective functions have been identified in vitro. For instance, LBP can function in vitro as an opsonin for Gram-negative bacteria (12) (13) (14) . However, most Gram-negative pathogens have long chain polysaccharides on their LPS that may limit the access of blood proteins to their lipid A, so LBP may not bind efficiently to pathogenic bacteria (15) . High concentrations of exogenously administered LBP have been reported to protect mice from lethal septic shock by an unknown mechanism, but it is not likely that such high levels of LBP are achieved under physiological conditions (16) . LBP can transfer LPS to high density lipoprotein (HDL) as well as to CD14, and LPS is nearly biologically inactive when complexed to HDL (17) . If this happens in vivo, LBP would be anti-inflammatory. Since the affinity of CD14 for LPS-LBP is greater than that of HDL, it is not clear whether the trafficking of LPS to HDL is a major pathway in vivo. High ratios of LBP to LPS may also inhibit the binding of LPS to lipid membranes and decrease the stimulatory effects of LPS on mononuclear cells (18) .
To study the in vivo functions of LBP, Jack et al. (19) and Wurfel et al. (20) independently engineered LBP-null mice by nearly identical gene-targeting techniques. While Wurfel et al. (20) found no difference in the survival of control and LBP knockout (KO) mice that had been infected with 5 ϫ 10 7 CFU Escherichia coli 0111:B4 (D. Golenbock, unpublished observations), Jack et al. (19) reported that LBP-KO mice are more susceptible to Salmonella typhimurium. This was the first evidence that LBP is necessary for innate resistance to infection. That report prompted us to investigate how LBP protects mice against Salmonella infections.
Materials and Methods

Mice
The genetic engineering of LBP-deficient mice was previously described (20) . LBP KO mice in the fifth generation of backcross to B6 were screened for the alleles of Nramp1 using PCR of genomic DNA (21) . Mice were then bred to be homozygous for the wild-type Nramp1 G169 (ItyR) allele on the B6/129 background. The mice were allowed free access to food and water. Control mice were BALB/c.D2 congenics that are homozygous for the wild-type Nramp1 G169 from DBA/2 mice (22) and (B6 ϫ 129)F 1 (Jackson). The F 1 mice have a single wild-type Nramp1, which makes them phenotypically resistant to Salmonella. Mice were raised under specific pathogen-free conditions and were infected when they were 6 -10 wk old.
Bacteria
S. typhimurium 14028 and Staphylococcus aureus 502A were obtained from American Type Culture Collection (Manassas, VA). Bacteria were grown overnight at 37°C in trypticase soy broth, then centrifuged for 20 min at 3000 ϫ g, and the pellet was washed in 20 ml pyrogen-free saline. We recentrifuged the bacteria and then resuspended the pellet in pyrogenfree normal saline to an absorbance of 0.65 at 600 A. This suspension was appropriately diluted in sterile saline. To kill the bacteria, we boiled them for 30 min before making the dilution for injection.
Infection
Bacteria were injected i.p. or i.v. in a lateral tail vein in 0.1 ml PBS or orally by gavage in 0.1 ml 0.1 M NaHCO 3 (23) . Mice were sacrificed at intervals, and the tissues were removed sterilely, homogenized, and then diluted in saline for quantitative cultures as previously described (23) . There were six mice in each group per time point.
Cytokine assays
Mice were sacrificed, and the fur was removed from the abdominal wall. We then injected 3 ml sterile, pyrogen-free saline into the peritoneal cavity and agitated the mice before sterilely withdrawing the injected saline with a 23-gauge needle and a syringe. Aspirated fluid was centrifuged at 250 ϫ g to remove cells, and the supernatant was frozen at Ϫ20°C until assayed. We used ELISA kits from R&D Systems (Minneapolis, MN) according to manufacturer's instructions to measure TNF-␣, macrophage inflammatory protein-2 (MIP-2), and cytokine-induced neutrophil chemoattractant (KC). TNF-␣ mRNA in spleen cells was measured using quantitative competitive RT-PCR as previously described (24) . Equal amounts of RNA from three representative animals in each group were mixed together and assayed by competitive RT-PCR. Endotoxin levels were measured with a chromogenic Limulus assay (BioWhittaker, Walkersville, MD). The lower limit of sensitivity is 0.1 endotoxin units.
LBP assay
LBP was measured in serum and peritoneal exudates (see above) using an ELISA method as previously described (25) .
Flow cytometry
Peritoneal washes were briefly chilled on melting ice, and the cells were counted using a Sysmex K-1000 (Baxter Diagnostics, McGaw Park, IL). The fluid was then centrifuged at 250 ϫ g, and the cell pellet was resuspended in PBS without Mg 2ϩ or Ca 2ϩ at 1 ϫ 10 7 cells/ml. Cells were stained with biotinylated RB6-8C5, a rat monoclonal anti-mouse Ly6g that specifically recognizes polymorphonuclear leukocytes (PMN) (26, 27) . Bound Ab was detected with FITC-labeled streptavidin. Cells were analyzed by flow cytometry with a Coulter EPICS Elite (Miami, FL). Total white blood cell (WBC) number was determined by hemocytometer counts. The percentage of RB6-8C5-labeled cells was calculated from the flow data and was multiplied by the total WBC to determine the number of PMN in the peritoneal exudate.
Endotoxin
Salmonella minnesota rough LPS was purchased from List Biologicals and diluted in nonpyrogenic saline for use.
Neutropenia
Mice were injected with 300 g mAb RB6-8C5. This was a larger dose than previously used (27) because the (B6 ϫ 129)F 1 mice were less responsive to this treatment than were BALB/c mice.
Statistics
The numbers of bacteria recovered (CFU) were expressed as the log 10 , and geometric means were determined. The difference between means was analyzed by two-tailed Student's t test using the Instat program (GraphPad, San Diego, CA). Kaplan-Meier survival curves were compared using the log-rank Mantel-Cox test.
Results
Mice were infected with 3 ϫ 10 3 S. typhimurium 14028 injected i.p. and observed daily thereafter. Fig. 1 shows the Kaplan-Meier survival curves for LBP KO and control BALB/c.D2 and (B6 ϫ 129)F 1 mice. The LBP KO mice began to die 4 days after infection, and 50% of them were dead by day 11, the day before the first control mice began to die. The difference between the LBP KO mice and the two control strains was highly significant (by MantelCox test, p ϭ Ͻ0.001). The difference between the two control strains was not significant ( p ϭ 0.23). Thus, LBP-deficient mice were more susceptible than control mice to infection with a virulent strain of S. typhimurium. We then infected LBP KO and B/c.D2 control mice to quantify the number of bacteria in their livers and spleens 3 days after infection. As shown in Table I , LBP KO mice had bacterial counts in those organs that were Ͼ10-fold higher than those in controls, which is consistent with the hypothesis that the higher mortality of LBP KO mice was due to more rapid growth of the bacteria.
We then infected both groups of mice by the oral route with 9 ϫ 10 7 S. typhimurium. No mice died in either group. We repeated the experiment and sacrificed mice 3, 5, and 7 days after infection. In contrast to the i.p. infected mice, there was no significant difference between colony counts of Salmonella in the livers, spleens, or mesenteric lymph nodes of LBP KO and control mice on any day ( p Ͼ 0.05; Table II ). This experiment was repeated with similar results. Thus, LBP played an important role in resistance to lethal salmonella peritonitis, but not in resistance to a sublethal intestinal infection. We also infected mice with 2 ϫ 10 3 S. typhimurium given i.v. and found no difference in colony counts in the livers and spleens of the two groups of mice 1, 3, and 5 days after infection (not shown).
To confirm that LBP levels increased in response to Salmonella infection, we measured serum and peritoneal levels of LBP after i.p. injection of bacteria. As shown in Table III , LBP levels in uninfected control mice were at the lower limit of detection in the serum and rose 25-fold 3 days after infection. In contrast, LBP was undetectable in the serum of infected LBP KO mice 3 days after infection, confirming that the mutation, which was designed to eliminate the methionine start sequence, abolished the synthesis of LBP protein under both normal and acute phase response conditions. In peritoneal fluid LBP was not detectable in uninfected mice, but rose in control mice to 10.8 ng/ml by 3 h after infection, and after 6 h to 24.7 ng/ml (Table III) . Since LBP was measured in 3 ml of a peritoneal wash, which we estimated to be a 10-to 50-fold dilution of the ascites fluid, the actual concentration of i.p. LBP was closer to 100 ng/ml at the earlier time point. LBP was not detectable in the peritoneal exudate of LBP KO at any time after S. typhimurium infection. S. aureus also raised the i.p. level of LBP in normal, but not LBP KO, mice.
The early deaths of LBP KO mice after i.p. infection suggested that the LBP KO mice had a defect in their innate immune response to Salmonella. We surmised that the observed protective effect of LBP might be due to its ability to facilitate the local inflammatory response to Salmonella in the peritoneal cavity, because LBP KO mice were more susceptible to i.p., but not oral or i.v., Salmonella infections, and LBP was detected in the peritoneal cavity by 3 h after infection. Therefore, we determined the percentage of PMN in the peritoneal exudate. In normal mice the percentage of PMN rose from Ͻ5 to nearly 20% by 3 h after infection (Fig. 2) and further increased to Ͼ50% by 6 h (not shown). In LPB KO mice there was a mean of only 0.8% PMN by 3 h after infection. The total number of PMN in LBP KO mice was only 1.5 ϫ 10 5 compared with 1.2 ϫ 10 6 in the B/c.D2 and 8.5 ϫ 10 5 in (129 ϫ B6)F 1 mice (Fig. 3 ). Even after 6 h the percentage of PMN in LBP KO mice was Ͻ25% (not shown). In contrast to their impaired response to Salmonella, LBP KO mice responded normally to injections of S. aureus and casein (0.2% in PBS; Sigma, St. Louis, MO), even though there was no i.p. LBP in their peritoneal exudates under any circumstances. Thus, LBP is not required for mice to respond to Gram-positive bacteria, and LBP KO mice do not have a global chemotactic defect.
To try to explain the paucity of PMNs in LBP KO mice, we measured the local concentrations of MIP-2 and KC, two glut-leuarg motif ϩ CXC chemokines that bind to the CXCR2 receptor and are chemotactic for PMN. As shown in Fig. 4 , control mice had 10 times more MIP-2 and 50 times more KC in their peritoneal exudates than did LBP KO mice 3 h after Salmonella were injected. However, both groups of mice had similar concentrations of KC and MIP-2 in the peritoneal washes after injection of S. aureus and casein.
To determine whether Salmonella infection per se was the stimulus for the PMN exudation we injected normal mice with heatkilled (HK) S. typhimurium. Fig. 5 shows the percentage of peritoneal exudate cells that were PMN in mice injected with either 3 ϫ 10 3 HK bacteria or a filtrate of that bacterial suspension. Both stimuli elicited an exudate that contained ϳ12% PMN, about half as many as were induced by live bacteria. Because live bacteria can multiply in the peritoneal cavity in 3 h, we also injected 3 ϫ 10 4 HK bacteria and its filtrate, which elicited a response comparable to that to live bacteria. The filtrate from 3 ϫ 10 4 S. typhimurium contained 12 endotoxin unit/ml, so the mice received only 1.2 endotoxin units, or ϳ0.2 ng LPS.
Having established that live Salmonella were not required to produce the local inflammatory exudate, we then asked whether other Gram-negative bacteria could elicit the response. As shown in Table IV , by 3 h after injection of 10 4 HK E. coli there was a nearly equivalent increase in the percentage of PMN in the peritoneal exudate (from Ͻ1 to Ͼ25%), and the responses to both HK Salmonella and HK E. coli were LBP dependent. Taken together, these results suggested that the exudation of PMN into the peritoneal cavity was primarily a response to LPS, and that this response was LBP dependent. To confirm this we first injected 1 ng Salmonella LPS (Re595) i.p. into (B6 ϫ 129)F 1 control mice and LBP KO mice and determined the percentage of PMN 3 h later (Fig. 6) . The LBP KO mice had only 4% PMN compared with 24% in the controls ( p ϭ Ͻ0.01). The concentrations of MIP-2 and KC in LBP KO mice was quite low compared with that in controls. We found no measurable KC and only 1.4 Ϯ 1.7 g/ml MIP-2 after LPS injection and only 71 Ϯ 23 g/ml KC and 66.7 Ϯ 20 g/ml MIP-2 after injecting 10 4 HK 14028. These levels are comparable to what we found in LBP KO mice that were injected with live Salmonella, but much lower than the levels in normal mice (Fig.  4) . When we injected Re595 into endotoxin-resistant C3H/HeJ and control C3H/OuJ mice, they had 8% PMN and 48%, respectively. These results indicate that the exudation of PMN into the peritoneal cavity is largely a response to LPS and that the response is dependent on both LBP and TLR4.
We then asked whether the PMN exudation was, in fact, beneficial to the host. To determine this we pretreated LBP KO mice with casein 3 h before we injected S. typhimurium i.p. Three days later we determined the numbers of bacteria in their livers and spleens. Pretreatment with casein reduced the colony counts in LBP KO mice by about 1 log (Fig. 7) . However, if we made the casein-treated mice neutropenic with the rat mAb RB6-8C5, the mice were not protected. This suggests that PMN were necessary for the beneficial effect of casein, making it unlikely that some other proinflammatory response to casein was responsible for the protection against Salmonella infection.
We also measured TNF-␣ in the infected mice because of the importance of TNF-␣ in response to Salmonella infections (28) and the recent report by Heinrich et al. that LBP KO mice could be protected from S. typhimurium by pretreatment with TNF (29) . There was no detectable TNF-␣ (Ͻ10 pg/ml) in the peritoneal washes taken from either LBP KO or control mice 3 and 6 h after injection of 3 ϫ 10 3 S. typhimurium. We then assessed the ability of LBP KO mice to make TNF-␣ in response to systemic infection. Since Heinrich et al. (29) could not detect circulating levels of TNF in Salmonella-infected mice we used a quantitative, competitive RT-PCR assay (24) to measure the amount of TNF-␣ mRNA in the spleens of infected mice. Uninfected LBP KO and control mice had similar levels of TNF-␣ mRNA in their spleens (ϳ2 ϫ 10 6 molecules/g RNA). On day 3 after i.p. infection splenic TNF-␣ mRNA increased 10-fold above the baseline in control mice. In contrast, there was no increase in TNF-␣ mRNA in infected LBP KO mice, even though they had higher bacterial counts and so would be expected to make more TNF-␣ mRNA (Table V) (24) . This confirms that LBP is important for multiple proinflammatory responses that are beneficial to mice with Salmonella peritonitis.
Discussion
In these experiments we confirmed the report by Jack et al. (19) that LBP-deficient mice are more susceptible to S. typhimurium infection after i.p. inoculation. However, we found that LBP-deficient mice were not more susceptible to oral or i.v. infection with S. typhimurium. To be certain that we had not missed a sublethal exacerbation of the oral infection in the LBP KO mice, we performed quantitative bacterial counts, and there was no statistical b Determined by cell sorting of exudate cells obtained 3 h after injection of HK bacteria. The value is from a pool of three mice in each group.
c Geometric mean (log 10 ) of three mice in each group. There were no significant differences between the WBC counts in the group ( p Ͼ 0.05, by t test).
difference in the numbers of bacteria in the livers, spleens, or mesenteric lymph nodes of LBP KO and control mice. Therefore, we concluded that LBP plays an important role only in Salmonella peritonitis.
To determine how LBP protects mice against Salmonella peritonitis we first looked for LBP in peritoneal exudates. By 3 h after infection normal mice had measurable levels of LBP, but LBP KO mice had no detectable LBP (Table III) . Since LBP was present in the peritoneum soon after infection, we concluded that it could affect the local response to Gram-negative infections, possibly by facilitating the synthesis of chemokines. The very rapid appearance of LBP in the peritoneum suggests that it may have been made locally and could be part of the local defenses against infection. There is recent evidence that type II pneumocytes in the lung can make LBP, and so contribute to lung defenses (30) , and that enteric epithelial cells secrete LBP when stimulated by proinflammatory cytokines (31) . Similarly, there may be peritoneal cells that synthesize LBP; this remains to be determined.
We then examined the cellular composition of the peritoneal exudate. Although Jack et al. (19) did not find a difference in cell number or type in the peritoneal exudates of LBP KO and normal mice, they did not analyze the composition of the exudate until 24 h after Salmonella infection. When we looked 3 and 6 h after Salmonella infection, we found that control mice had 10 -15 times more PMN in the peritoneal exudates than did LBP KO mice. (We found that LBP also accelerates the influx of PMN in mice with Klebsiella peritonitis (D. Golenbock, unpublished observations).) In contrast, PMN exudation in response to the Gram-positive pathogen S. aureus and the nonspecific stimulant, casein was indistinguishable in LBP KO and control mice. Thus, it appears that LBP mediates acute inflammation in response to Gram-negative bacteria, but not other stimuli.
Since the LBP KO mice had fewer PMN after Salmonella infection, we predicted that they would also have lower levels of CXC chemokines in the exudate fluids. Indeed, the levels of two neutrophil chemokines, KC and MIP-2, were Ͼ10 -50 times higher in control mice than in LBP KO mice (Fig. 4) . In contrast, there were no significant differences in KC and MIP-2 levels in response to S. aureus and casein. These results showed that i.p. LBP plays an important role in the generation of CXC chemokines in response to Gram-negative, but not Gram-positive, bacteria. Since HK Salmonella and E. coli were also chemotactic in an LBP-dependent manner, we tested the response to purified LPS and found that it was also chemotactic in an LBP-dependent manner. It is most likely that LBP facilitates the interaction of LPS with host cells that synthesize and release chemokines. Vesy et al. (17) have recently shown that outer membrane blebs from S. typhimurium stimulate human macrophages to make IL-8, and that LBP enhances the potency of the blebs 100-fold. It is likely that we have shown the equivalent response in vivo in mice. In vitro, mouse peritoneal macrophages are induced to make MIP-2 by as little as 0.1 ng LPS (32), and we injected only 1 ng LPS i.p.
Having established that LBP promotes acute inflammation in Salmonella peritonitis, we then showed that this response is critical for an effective host response to Salmonella peritonitis. We were able to make LBP KO mice more resistant to this infection by pretreating them with casein, which established an exudation of PMN independent of LBP. Casein-pretreated LBP KO mice had a 10-fold reduction in bacterial counts in their livers and spleens. Most importantly, casein pretreatment was ineffective in mice that were simultaneously made neutropenic with the mAb RB6-8C5 (Fig. 7) . Thus, the beneficial effect of casein was due to its chemotactic properties, not to some other proinflammatory effect.
PMN are the first cells to arrive at sites of infection and are therefore one of the first lines of defense against bacterial infections. PMN are not usually considered to be important in the host defense against Salmonella, as these organisms are adapted to grow inside macrophages. However, we and others have shown that PMN efficiently kill Salmonella in vitro (27, 33) , and that neutropenic mice are much more susceptible to Salmonella infections (27, 34, 35) . In vivo, PMN could be acting directly to kill some of the injected Salmonella, thereby reducing the inoculum enough to slow the course of infection. PMN could also be acting in synergy with macrophages, releasing O 2 ⅐ from their respiratory burst to combine with macrophage NO to make peroxynitrite, a potent antimicrobial product (36) . Alternatively, PMN are also a source of proinflammatory cytokines that could activate macrophages (37) . While the exact mechanism of action of PMN in Salmonella infections has not been established, the results of this study provide further evidence for the role of PMN in resistance to Salmonella infections.
PMN are recruited from the circulation by a variety of chemotactic stimuli that include the complement-derived anaphylatoxins, various neutrophil-active CXC chemokines, and leukotriene B4 (38) . Many chemotactic signals, LPS, and proinflammatory chemokines can also activate PMN, as measured by generation of NADPH oxidase and up-regulation of various surface receptors (39 -42) . Since LBP-LPS can also activate PMN (39), as can macrophage-derived cytokines such as TNF-␣ (43), it is possible that LBP KO mice not only had fewer PMN in the peritoneal cavity, but that these PMN were less activated and thus less bactericidal.
Although we have not established that KC and MIP-2 are primarily responsible for PMN exudation in Salmonella peritonitis, those chemokines have been shown to mediate the inflammatory response to cecal perforation (44, 45) . The source of MIP-2 and KC in acute peritonitis has not been established. Peritoneal mesothelial cells can make CXC chemokines in response to TNF-␣ and IL-1, but not LPS (46) , so these were probably not the source of KC and MIP-2 in our experiments. Peritoneal macrophages or mast cells (44) can also make TNF-␣ and IL-1, but we were unable to detect TNF-␣ in the peritoneal exudate. Therefore, we consider it more likely that either peritoneal macrophages or mast cells made CXC chemokines after being stimulated by LPS in an LBPdependent manner (47, 48) .
If PMN are important in defending against Salmonella peritonitis, and LBP-deficient mice have fewer PMN than normal mice in the first few hours after infection, why were the LBP-deficient mice not more susceptible to oral infection? This could be explained by the different sources of CXC chemokines in the peritoneum and the gut. In the gut, mucosal epithelial cells, not macrophages, make CXC chemokines in the intestine during enteric infections (49, 50) . Although stimulated cultured intestinal epithelial cells can secrete LBP (31), we found that T 84 colonic epithelial cells do not respond to LPS in vitro (49) , and neither MD-2 nor CD14 is constitutively expressed on intestinal epithelial cell lines (51, 52) .
Since LPS activates NF-B in macrophages, it induces the expression of many genes (53, 54) . Therefore, since LBP deficiency impairs these responses, it is difficult to exclude the possibility that LBP KO mice have relative deficiencies of several cytokines or chemokines other than KC and MIP-2. TNF-␣ is also required for resistance to Salmonella (28, 55, 56) , so low levels of this cytokine could contribute to the susceptibility of LBP KO mice. Indeed, although they could not detect circulating TNF in infected mice, Heinrich et al. (29) showed that exogenous TNF protected LBP KO mice from S. typhimurium peritonitis. Although we could not detect TNF-␣ in the peritoneal wash 3 h after bacteria were injected i.p., the ELISA may not have been sufficiently sensitive because our sample was diluted. However, we did find that Salmonella infection stimulated a 10-fold increase in TNF-␣ mRNA in the spleens of control mice, but not in LBP KO mice (Table IV) . This difference was particularly striking because LBP KO mice were more severely infected, and the amount of TNF-␣ mRNA in spleens is normally proportional to the severity of the Salmonella infection (24) . TNF-␣ can be released from mast cells, which are abundant in the mouse peritoneum, and mast cell-derived TNF-␣ plays a critical role in recruiting PMN to the peritoneum (57) . Therefore, i.p. injection of TNF-␣ may have stimulated PMN chemotaxis (29) , just as casein did in our experiments. Alternatively, mesothelial cells may have been stimulated by the TNF to make CXC chemokines (58) .
We cannot explain why these LBP KO mice had lower levels of TNF-␣ mRNA after Salmonella infection but normal levels of circulating TNF-␣ when injected i.v. with E. coli LPS (20) . LPS on intact bacteria is clearly differently configured than LPS in suspension and so may interact differently with LBP and cellular receptors when in suspension. If so, since animals normally encounter LPS in the context of Gram-negative bacterial infections, the response of LBP KO mice to Salmonella is probably more physiologically relevant. It is also possible that subtle differences in the lipid A structures from E. coli and S. typhimurium (59) could explain the apparently contradictory results. For instance, Netea et al. (60) found that LPS from E. coli and S. typhimurium were not biologically equivalent when injected into mice. E. coli LPS caused PMN to accumulate in the lungs, whereas Salmonella LPS directed PMN primarily to the livers. They did not examine the role of LBP in those responses. In our experiments i.p. injections of HK E. coli, HK Salmonella, and purified LPS provoked equivalent acute inflammatory responses that were TLR4 and LBP dependent (Fig. 6) .
Although the i.p. route of Salmonella infection is not physiological, and so may not be relevant to the pathogenesis of naturally occurring Salmonella infections, it does indicate that LBP plays an important role in Gram-negative peritonitis and probably in other systemic Gram-negative infections. LBP is part of the innate immune system, which has evolved to recognize and respond to the lipid A in LPS, a conserved structure in most Gram-negative bacteria. TLR4 (61) and now LBP have been shown to be required for optimal resistance to Salmonella infections. In the absence of LBP, acute inflammation is delayed, and the host is more susceptible to Gram-negative bacterial infections.
